Eric W. Humke, M.D., Ph.D.
Senior Vice President, Clinical Research and Development

Dr. Humke joined IGM in 2019 and currently serves as our Senior Vice President of Clinical Research and Development. Prior to joining us, Dr. Humke was Senior Medical Director at Genentech where he led numerous clinical programs from research through Phase 2 trials in Research & Early Clinical Development. These programs evaluated several antibody drug conjugates for multiple myeloma, lung, pancreatic, ovarian, and endometrial cancer and various small molecule inhibitors for multiple myeloma, lung and breast cancer. Prior to joining Genentech, he was an Instructor of Medicine in the Division of Oncology at the Stanford University School of Medicine where he conducted basic science research and cared for patients in the oncology clinic. Dr. Humke received a B.S. in Neuroscience from Brown University and an M.D., Ph.D. from the University of Michigan. Dr. Humke completed his internal medicine residency at Washington University in St. Louis (Barnes-Jewish Hospital) and a medical oncology fellowship at Stanford University.